Times News Network
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas Narasimhan announced a plan to simplify the organizational chart. Novartis (ticker: NVS) will chop as many as 8,000 positions out of the total of … Read More “Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan” »
A general view of the Kremlin, Red Square and St. Basil’s Cathedral in central Moscow. AFP via Getty Images Text size Russia’s first default on its foreign debt in more than 100 years is the latest sign that the sanctions levied against the country after the Ukraine invasion have consequences. But it’s probably not that … Read More “The Russian Default Is Less Worrisome Than It Appears. Keep Watching Oil.” »
U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 million) to buy an 8.1% percent stake in French vaccines company , as the companies announced developments in their partnership to tackle the Lyme disease. Pfizer will buy the stake in Valneva, which is also working on its COVID-19 vaccine, at a price … Read More “Pfizer to buy 8.1 percent stake in French vaccines company Valneva” »
Text size Pfizer’s investment in Valneva will help support development of Lyme disease program. AFP via Getty Images Pfizer has agreed to invest €90.5 million ($95.25 million) in an 8.1% stake in Valneva to boost the two companies’ development of a vaccine against Lyme disease. The U.S. pharmaceutical giant will buy Valneva (ticker: VALN.France) at … Read More “Pfizer To Buy 8.1% Stake In French Vaccines Company Valneva” »
CHICAGO (CBS) — COVID-19 vaccines for kids as young as 6 months old will be available as soon as next week. The Food and Drug Administration approved shots from both Pfizer and Moderna for babies, toddlers, and young children on Friday. The Centers for Disease Control and Prevention still need to sign off, but that … Read More “COVID-19 vaccines to be available for younger children soon, but many parents still hesitant” »
Covid vaccines for the youngest Americans could be rolled out in a matter of days after the Food and Drug Administration recommended approving both the Moderna and Pfizer shots, despite some experts warning that they are not needed for children under the age of five. On Wednesday, members of the Vaccines and Related Biological Products … Read More “FDA approves covid vaccines in children aged six months to five years” »
COVID vaccines for youngest kids could be available in days 01:58 COVID-19 vaccine shots for U.S. infants, toddlers and preschoolers moved a step closer Wednesday. The Food and Drug Administration’s outside vaccine advisers gave a thumbs-up to Moderna’s two-shot vaccine and also to Pfizer-BioNTech’s three-shot series for the young age group. The panel of experts … Read More “COVID-19 vaccines for kids under 5: FDA advisers move a step closer to authorizing Moderna, Pfizer shots” »
Modern Covid vaccine should be made available to children ages six to 17, an independent panel at the Food and Drug Administration said Tuesday – as the U.S. Covid wave fell on all fronts. All 22 members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted to approve the two-dose jab for the … Read More “Modernas Covid vaccine is more likely to trigger heart inflammation in young and middle-aged men” »
American multinational pharmaceutical and biotechnology corporation, Pfizer, has completed the acquisition of clinical-stage biopharmaceutical firm ReViral for a total deal value of up to $525m. According to reports, Pfizer entered a definitive agreement to acquire ReViral and its respiratory syncytial virus (RSV) treatment candidates in April this year. Reportedly, the deal value comprises upfront and … Read More “Pfizer acquires clinical-stage biopharma firm ReViral for up to $525m” »
WASHINGTON (AP) — Federal health officials said Sunday that kid-sized doses of Pfizer’s COVID-19 vaccines appear to be safe and effective for kids under 5, a key step toward a long-awaited decision to begin vaccinating the youngest American children. The Food and Drug Administration posted its analysis of the Pfizer shot ahead of a Wednesday … Read More “FDA: Pfizer COVID-19 Shot Appears Effective For Kids Under 5” »
